Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-29 @ 1:37 PM
Study NCT ID:
NCT00918333
Status:
COMPLETED
Last Update Posted:
2020-03-10
First Post:
2009-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06
Start Date Type:
ACTUAL
Primary Completion Date:
2015-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-16
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-01
First Submit QC Date:
None
Study First Post Date:
2009-06-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-19
Results First Submit QC Date:
None
Results First Post Date:
2018-05-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-02
Last Update Post Date:
2020-03-10
Last Update Post Date Type:
ACTUAL